Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2006 3
2007 7
2008 10
2009 5
2010 4
2011 6
2012 12
2013 12
2014 9
2015 10
2016 11
2017 11
2018 6
2019 10
2020 21
2021 47
2022 37
2023 32
2024 16

Text availability

Article attribute

Article type

Publication date

Search Results

244 results

Results by year

Filters applied: . Clear all
Page 1
Role of NAD+ in regulating cellular and metabolic signaling pathways.
Amjad S, Nisar S, Bhat AA, Shah AR, Frenneaux MP, Fakhro K, Haris M, Reddy R, Patay Z, Baur J, Bagga P. Amjad S, et al. Among authors: haris m. Mol Metab. 2021 Jul;49:101195. doi: 10.1016/j.molmet.2021.101195. Epub 2021 Feb 17. Mol Metab. 2021. PMID: 33609766 Free PMC article. Review.
Cytokine- and chemokine-induced inflammatory colorectal tumor microenvironment: Emerging avenue for targeted therapy.
Bhat AA, Nisar S, Singh M, Ashraf B, Masoodi T, Prasad CP, Sharma A, Maacha S, Karedath T, Hashem S, Yasin SB, Bagga P, Reddy R, Frennaux MP, Uddin S, Dhawan P, Haris M, Macha MA. Bhat AA, et al. Among authors: haris m. Cancer Commun (Lond). 2022 Aug;42(8):689-715. doi: 10.1002/cac2.12295. Epub 2022 Jul 5. Cancer Commun (Lond). 2022. PMID: 35791509 Free PMC article. Review.
Harnessing the potential of CAR-T cell therapy: progress, challenges, and future directions in hematological and solid tumor treatments.
Dagar G, Gupta A, Masoodi T, Nisar S, Merhi M, Hashem S, Chauhan R, Dagar M, Mirza S, Bagga P, Kumar R, Akil ASA, Macha MA, Haris M, Uddin S, Singh M, Bhat AA. Dagar G, et al. Among authors: haris m. J Transl Med. 2023 Jul 7;21(1):449. doi: 10.1186/s12967-023-04292-3. J Transl Med. 2023. PMID: 37420216 Free PMC article. Review.
Single-Cell Analyses Identify Brain Mural Cells Expressing CD19 as Potential Off-Tumor Targets for CAR-T Immunotherapies.
Parker KR, Migliorini D, Perkey E, Yost KE, Bhaduri A, Bagga P, Haris M, Wilson NE, Liu F, Gabunia K, Scholler J, Montine TJ, Bhoj VG, Reddy R, Mohan S, Maillard I, Kriegstein AR, June CH, Chang HY, Posey AD Jr, Satpathy AT. Parker KR, et al. Among authors: haris m. Cell. 2020 Oct 1;183(1):126-142.e17. doi: 10.1016/j.cell.2020.08.022. Epub 2020 Sep 21. Cell. 2020. PMID: 32961131 Free PMC article.
Exploring Dysregulated Signaling Pathways in Cancer.
Nisar S, Hashem S, Macha MA, Yadav SK, Muralitharan S, Therachiyil L, Sageena G, Al-Naemi H, Haris M, Bhat AA. Nisar S, et al. Among authors: haris m. Curr Pharm Des. 2020;26(4):429-445. doi: 10.2174/1381612826666200115095937. Curr Pharm Des. 2020. PMID: 31939726 Review.
miRNAs as novel immunoregulators in cancer.
Lone SN, Bhat AA, Wani NA, Karedath T, Hashem S, Nisar S, Singh M, Bagga P, Das BC, Bedognetti D, Reddy R, Frenneaux MP, El-Rifai W, Siddiqi MA, Haris M, Macha MA. Lone SN, et al. Among authors: haris m. Semin Cell Dev Biol. 2022 Apr;124:3-14. doi: 10.1016/j.semcdb.2021.04.013. Epub 2021 Apr 27. Semin Cell Dev Biol. 2022. PMID: 33926791 Review.
Claudin-1, A Double-Edged Sword in Cancer.
Bhat AA, Syed N, Therachiyil L, Nisar S, Hashem S, Macha MA, Yadav SK, Krishnankutty R, Muralitharan S, Al-Naemi H, Bagga P, Reddy R, Dhawan P, Akobeng A, Uddin S, Frenneaux MP, El-Rifai W, Haris M. Bhat AA, et al. Among authors: haris m. Int J Mol Sci. 2020 Jan 15;21(2):569. doi: 10.3390/ijms21020569. Int J Mol Sci. 2020. PMID: 31952355 Free PMC article. Review.
244 results